Video

Q&A With Mary Norine Walsh From St. Vincent Hospital: New Therapies Provide Hope for Heart Failure Patients

Author(s):

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

Mary Norine Walsh, MD, from St. Vincent Hospital in Indianapolis discussed these new options as well as other areas of interest for the condition during the European Society of Cardiology's annual conference in London. In addition to her duties at the hospital Walsh also serves as the Vice President of the American College of Cardiology.

Whether it is the general practitioner, the cardiologist, or the cardiac surgeon, the landscape of heart failure treatment is constantly changing. Because of this learning remains an important factor in daily practice.

New medications and treatments for heart failure have been developed over the past couple of decades but there is still more work to be done. This includes improving existing technology and also adding new tools in the fight against the condition.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.